10-Q: Amesite Inc. Reports Q3 2025 Results, Focuses on AI-Driven Solutions and Cost Reduction

Amesite Inc. reports a net loss for Q3 2025, but highlights a strategic shift towards AI-driven solutions and a reduction in cash burn.

Summary

• Amesite Inc. reported its financial results for the quarter ended March 31, 2025.
• The company is focusing on developing and marketing AI-driven solutions, including its higher ed platform and healthcare app, NurseMagic.
• Amesite is addressing concerns about its ability to continue as a going concern by planning financing transactions, including potential common stock offerings.
• Net revenue for the three months ended March 31, 2025, was $30,690, compared to $34,261 for the same period in 2024.
• Net revenue for the nine months ended March 31, 2025, was $54,700, compared to $139,037 for the same period in 2024.
• The company experienced a net loss of $663,418 for the three months ended March 31, 2025, compared to a net loss of $1,425,912 for the three months ended March 31, 2024.
• The net loss for the nine months ended March 31, 2025, was $2,693,100, compared to $3,222,216 for the nine months ended March 31, 2024.
• As of March 31, 2025, cash and cash equivalents totaled $2,858,963.
• The company is working to regain compliance with Nasdaq listing requirements.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is focusing on promising AI-driven solutions and reducing costs, it faces significant challenges, including going concern doubts and Nasdaq compliance issues. The decrease in revenue is also a concern.

Positives

• The company is strategically pivoting to AI-driven solutions, which management believes will supplant other similar products in the mid to long term.
• Amesite has successfully reduced its cash burn, indicating improved cost management.
• The company has seen increases in marketing qualified leads (MQLs) while reducing overall sales and marketing spend.
• Amesite closed a public offering of common stock on January 8, 2025, providing additional capital.
• The company is taking steps to remediate material weaknesses in internal controls over financial reporting.

Negatives

• Amesite has a history of net losses and negative cash flows from operating activities.
• The company's revenue decreased for both the three and nine months ended March 31, 2025.
• There is substantial doubt about the company's ability to continue as a going concern.
• Amesite received a Nasdaq deficiency letter and is working to regain compliance with listing requirements.
• The company identified material weaknesses in its disclosure controls and procedures and internal control over financial reporting.

Risks

• The company's ability to obtain additional funds for its operations is uncertain.
• Amesite's success depends on its ability to obtain and maintain intellectual property protection.
• The company relies on third parties to conduct its business and studies.
• Amesite's business is subject to the impact of government regulation and developments relating to competitors or the industry.
• Failure to maintain compliance with Nasdaq listing requirements could result in delisting and adverse consequences.

Future Outlook

Management plans to generate cash by completing financing transactions, which may include offerings of common stock, but these plans are subject to market conditions and are not within the company's control.

Management Comments

• We have strongly pivoted to growing our customer base while reducing risk and losses, resulting in a larger client base, a short-term reduction in overall revenue and a dramatic reduction in cash burn.
• We continue to believe that AI-powered B2B and B2C solutions, priced affordably, will supplant other similar products in the mid to long term.
• We have focused all new development work on delivering AI tools to markets hungry for increased capability that immediately impacts both their performance and their bottom line.

Industry Context

The company is focusing on AI-driven solutions, which aligns with the broader industry trend of incorporating AI into various sectors, including education and healthcare.

Comparison to Industry Standards

• It is difficult to compare Amesite directly to industry standards due to its unique combination of higher education and healthcare AI solutions.
• Companies like Coursera and 2U are major players in the online education space, but they do not have a healthcare AI app like NurseMagic.
• In the healthcare AI space, companies like IBM Watson Health and Google Health are much larger and have a broader range of products and services.
• Amesite's smaller size and focus on specific niches may allow it to be more agile and responsive to customer needs, but it also faces challenges in competing with larger, more established companies.

Stakeholder Impact

• Shareholders face the risk of delisting from Nasdaq and potential dilution from future stock offerings.
• Employees may be affected by cost-cutting measures and the company's uncertain financial situation.
• Customers may benefit from the company's focus on AI-driven solutions, but also face the risk of service disruptions if the company's financial situation worsens.
• Creditors face the risk of non-payment if the company is unable to continue as a going concern.

Next Steps

• The company intends to take all reasonable measures available to maintain compliance under the Nasdaq Listing Rules and remain listed on Nasdaq.
• The Company will take steps to remediate the material weaknesses through the documentation of processes and controls for transactions that occur in the course of business, and in the financial statement close, reporting and disclosure processes.
• The Company will formalize our process and documentation for monitoring internal control over financial reporting.

Key Dates

Keywords

financial results, AI-driven solutions, NurseMagic, going concern, Nasdaq compliance, stock offering, net loss, revenue, Amesite